Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Solute carrier family 25 member 15 pseudogene 3 (SLC25A15P3)** is a human pseudogene located at NCBI Gene 100422635 and Ensembl ENSG00000251299. It is annotated as a pseudogene related to the solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15, but it does not encode a functional protein[1][3][5][6]. Unlike its functional parent gene SLC25A15, which is involved in ornithine transport across the mitochondrial membrane, SLC25A15P3 is classified as a noncoding, nonfunctional sequence. Pseudogenes like SLC25A15P3 may have regulatory roles at the RNA level, but there is no evidence to support their status as therapeutic or druggable targets, nor any associated drugs, disease roles, or safety concerns specifically for this pseudogene[3][5][10]. **Essential context and supporting details:** - SLC25A15P3 is clearly identified as a *pseudogene*, not an active transporter, enzyme, or receptor[1][3][5][6]. - As a pseudogene, it is not considered a therapeutic target in drug discovery or clinical research, though pseudogenes in general may sometimes participate in gene regulation at the RNA level[10]. - The canonical gene SLC25A15 encodes a mitochondrial ornithine transporter involved in the urea cycle; by contrast, SLC25A15P3 does not code for a protein and has no documented function in health or disease[1][6][7]. - The presence of multiple similarly named pseudogenes (e.g., SLC25A15P1, P2, P4) reflects the gene family's duplication and evolutionary inactivity[6][7]. - No drugs, mechanisms of action, biomarkers, or notable safety concerns are associated with this pseudogene, and it should not be confused with its protein-coding parent gene SLC25A15[3][5][6][7][10]. This entry is primarily provided for genomic annotation and research purposes and is not actionable as a drug or disease target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 25 member 15 pseudogene 3 (SLC25A15P3).